Cuyue Tang

4.0k citations

66 papers · 2.2k indexed · h-index 25

Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism 28
Oncology top 5%
- Drug Transport and Resistance Mechanisms 19
Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology 5
Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 28
Endocrinology, Diabetes and Metabolism top 5%
Genetics
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 13
Computational Theory and Mathematics
- Computational Drug Discovery Methods 7
Molecular Biology
- Receptor Mechanisms and Signaling 7
Pediatrics, Perinatology and Child Health
- Pharmacological Effects and Toxicity Studies 6
Toxicology
- Bioactive Compounds and Antitumor Agents 5

Co-authors: Thomayant Prueksaritanont Jiunn H. Lin Magang Shou Yue Qiu Thomas H. Rushmore Mei Qin Raju Subramanian Thomas A. Baillie
Cited by: Pharmacology Oncology Biochemistry
Journals: Journal of Clinical Investigation (1 paper)Blood (2 papers)Cancer Research (2 papers)
Partner nations: United States China Japan

In The Last Decade

Cuyue Tang

66 papers receiving 2.1k citations

Peers

Countries citing papers authored by Cuyue Tang

Since Specialization

Citations

This map shows the geographic impact of Cuyue Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cuyue Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cuyue Tang more than expected).

Fields of papers citing papers by Cuyue Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cuyue Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cuyue Tang. The network helps show where Cuyue Tang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Cuyue Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cuyue Tang Line = papers co-authored together Cuyue Tang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer’s disease Alzheimer s Research & Therapy ·Jean‐François Blain,Matthew G. Bursavich,Emily A. Freeman,Lori Hrdlicka,Hilliary Hodgdon,Ting Chen,Don E. Costa,Bryce A. Harrison,Sudarshan Kapadnis,Deirdre Murphy,Scott Nolan,Zhiming Tu,Cuyue Tang,Duane A. Burnett,Holger Patzke,Gerhard Koenig	2016	16
2	Intracellular Retention of Three Quinuclidine Derivatives in Caco-2 Permeation Experiments: Mechanisms and Impact on Estimating Permeability and Active Efflux Ratio Drug Metabolism Letters ·Hong Jin,Sudarshan Kapadnis,Ting Chen,Dooyoung Lee,Andrew J. McRiner,Andrew Cook,Duane A. Burnett,Gerhard Koenig,Cuyue Tang	2016	2
3	Concentration-response relationship of the α7 nicotinic acetylcholine receptor agonist FRM-17874 across multiple in vitro and in vivo assays Biochemical Pharmacology ·Milan Stoiljković,Liza Leventhal,Angela Chen,Ting Chen,Rachelle Driscoll,Dorothy G. Flood,Hilliary Hodgdon,Raymond S Hurst,Dávid Nagy,Timothy M. Piser,Cuyue Tang,Matthew Townsend,Zhiming Tu,Daniel Bertrand,Gerhard Koenig,Mihály Hajós	2015	24
4	A dynamic view to the modulation of phosphorylation and O-GlcNAcylation by inhibition of O-GlcNAcase Computational Biology and Chemistry ·Cuyue Tang,Devin Welty	2013	1
5	ADME of Biologics—What Have We Learned from Small Molecules? The AAPS Journal ·Thomayant Prueksaritanont,Cuyue Tang	2012	49
6	3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive allosteric modulators of mGluR2 for the treatment of schizophrenia: Hit-to-lead efforts Bioorganic & Medicinal Chemistry Letters ·Edward J. Brnardic,Mark E. Fraley,R. M. Garbaccio,M. E. Layton,John M. Sanders,Chris Culberson,Marlene A. Jacobson,Brian C. Magliaro,Pete H. Hutson,Julie A. O’Brien,Sarah L. Huszar,Jason M. Uslaner,Kerry L. Fillgrove,Cuyue Tang,Yuhsin Kuo,Sylvie M. Sur,George D. Hartman	2010	30
7	Antagonism of T-type calcium channels inhibits high-fat diet–induced weight gain in mice Journal of Clinical Investigation ·Victor N. Uebele,Anthony L. Gotter,Cindy E. Nuss,Richard L. Kraus,Scott M. Doran,Susan L. Garson,Duane R. Reiss,Yuxing Li,James C. Barrow,Thomas S. Reger,Zhi-Qiang Yang,Jeanine Ballard,Cuyue Tang,Joseph M. Metzger,Sheng-Ping Wang,Kenneth S. Koblan,John J. Renger	2009	61
8	CYP2C75-Involved Autoinduction of Metabolism in Rhesus Monkeys of Methyl 3-Chloro-3′-fluoro-4′-{(1 R)-1-[({1-[(trifluoroacetyl)amino]cyclopropyl}carbonyl)amino]ethyl}-1,1′-biphenyl-2-carboxylate (MK-0686), a Bradykinin B1 Receptor Antagonist Journal of Pharmacology and Experimental Therapeutics ·Cuyue Tang,Brian Carr,Frédéric Poignant,Bennett Ma,Stacey L. Polsky-Fisher,Yuhsin Kuo,Kristie Strong‐Basalyga,Alisha Norcross,Karen Richards,Roy Eisenhandler,Edward J. Carlini,Christina N. Di Marco,Scott D. Kuduk,Nathan X. Yu,Conrad E. Raab,Tom Rushmore,Clay B. Frederick,Mark G. Bock,Thomayant Prueksaritanont	2008	6
9	2-Aminobenzophenones as a Novel Class of Bradykinin B₁Receptor Antagonists Journal of Medicinal Chemistry ·Dai‐Shi Su,John L. Lim,Elizabeth Tinney,Bang-Lin Wan,Kathy Murphy,Duane R. Reiss,C. Meacham Harrell,Stacy S. O’Malley,Rick W. Ransom,Raymond S.L. Chang,Douglas J. Pettibone,Jian Yu,Cuyue Tang,Thomayant Prueksaritanont,Roger Freidinger,Mark G. Bock,Neville J. Anthony	2008	13
10	A new class of bradykinin B1 receptor antagonists with high oral bioavailability and minimal PXR activity Bioorganic & Medicinal Chemistry Letters ·Dong-Mei Feng,Robert M. DiPardo,Jenny Wai,Ronald K. Chang,Christina N. Di Marco,Kathy Murphy,Richard W. Ransom,Duane R. Reiss,Cuyue Tang,Thomayant Prueksaritanont,Douglas J. Pettibone,Mark G. Bock,Scott D. Kuduk	2007	15
11	Potent bradykinin B1 receptor antagonists: 4-Substituted phenyl cyclohexanes Bioorganic & Medicinal Chemistry Letters ·Dai‐Shi Su,John L. Lim,M. Kristine Markowitz,Bang-Lin Wan,Kathy Murphy,Duane R. Reiss,C. Meacham Harrell,Stacy S. O’Malley,Rick W. Ransom,Raymond S.L. Chang,Douglas J. Pettibone,Cuyue Tang,Thomayant Prueksaritanont,Roger Freidinger,Mark G. Bock	2007	5
12	5-Piperazinyl pyridine carboxamide bradykinin B1 antagonists Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,Christina N. Di Marco,Ronald K. Chang,Michael R. Wood,June J. Kim,Kathy M. Schirripa,Kathy Murphy,Richard W. Ransom,Cuyue Tang,Maricel Torrent,Sookhee Ha,Thomayant Prueksaritanont,Douglas J. Pettibone,Mark G. Bock	2006	10
13	Rifampin Induces the in Vitro Oxidative Metabolism, but Not the in Vivo Clearance of Diclofenac in Rhesus Monkeys Drug Metabolism and Disposition ·Thomayant Prueksaritanont,Chunze Li,Cuyue Tang,Yuhsin Kuo,Kristie Strong‐Basalyga,Brian Carr	2006	4
14	Bradykinin B1 antagonists: SAR studies in the 2,3-diaminopyridine series Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,Ronald K. Chang,Christina Ng,Kathy Murphy,Richard W. Ransom,Cuyue Tang,Thomayant Prueksaritanont,Roger Freidinger,Douglas J. Pettibone,Mark G. Bock	2005	14
15	Acyl Glucuronidation and Glucosidation of a New and Selective Endothelin ETA Receptor Antagonist in Human Liver Microsomes Drug Metabolism and Disposition ·Cuyue Tang,Jerome Hochman,Bennett Ma,Raju Subramanian,Kamlesh P. Vyas	2003	35
16	Mechanistic Studies on Metabolic Interactions between Gemfibrozil and Statins Journal of Pharmacology and Experimental Therapeutics ·Thomayant Prueksaritanont,Jamie J. Zhao,Bennett Ma,Brad Roadcap,Cuyue Tang,Yue Qiu,Lida Liu,Jiunn H. Lin,Paul G. Pearson,Thomas A. Baillie	2002	219
17	Effects of Fibrates on Metabolism of Statins in Human Hepatocytes Drug Metabolism and Disposition ·Thomayant Prueksaritanont,Cuyue Tang,Yue Qiu,Lillian Mu,Raju Subramanian,Jiunn H. Lin	2002	249
18	Inhibition Kinetics of Monoclonal Antibodies against Cytochromes P450 Drug Metabolism and Disposition ·Mei Qin,Cuyue Tang,Yuh J. Lin,Thomas H. Rushmore,Magang Shou	2002	10
19	P450 interaction with farnesyl-protein transferase inhibitors metabolic stability, inhibitory potency, and P450 binding spectra in human liver microsomes 1 1Abbreviations: FTI, farnesyl-protein transferase inhibitor; FTase, farnesyl-protein transferase; and LC-MS, liquid chromatography-mass spectrometry. Biochemical Pharmacology ·Masato Chiba,Cuyue Tang,William Neway,Theresa M. Williams,S. J. DESOLMS,Christopher J Dinsmore,John Wai,Jiunn H. Lin	2001	19
20	Simultaneous determination of urinary free cortisol and 6β-hydroxycortisol by liquid chromatography–atmospheric pressure chemical ionization tandem mass spectrometry and its application for estimating hepatic CYP3A induction Journal of Chromatography B Biomedical Sciences and Applications ·Cuyue Tang,Kelem Kassahun,Ian McIntosh,Janice Brunner,A.David Rodrigues	2000	31

About Cuyue Tang

Cuyue Tang is a scholar working on Pharmacology, Toxicology and Genetics, having authored 66 papers that have together received 2.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (28 papers), Drug Transport and Resistance Mechanisms (19 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers), Computational Drug Discovery Methods (7 papers), Receptor Mechanisms and Signaling (7 papers), Pharmacological Effects and Toxicity Studies (6 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). The work is most often cited by research in Pharmacology (839 citations), Oncology (627 citations) and Biochemistry (132 citations). Cuyue Tang has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Thomayant Prueksaritanont, Jiunn H. Lin, Magang Shou, Yue Qiu, Thomas H. Rushmore, Mei Qin, Raju Subramanian, Thomas A. Baillie, A. David Rodrigues and Bennett Ma. Their work appears in journals such as Journal of Clinical Investigation, Blood and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact